powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1215460316
Deya Obaidat
M.B.B.S
Rheumatology
Indianapolis,
IN
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 150021
Hospital
CCN 150045
Hospital
CCN 150091
Hospital
CCN 150101
Hospital
CCN 150146
Hospital
QUALITY · MIPS · 2024
Final MIPS score
83.5
Quality
70.0
Cost
75.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.36%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
3,445
Beneficiaries
—
Total drug cost
$6.4M
Distinct drugs
43
Brand share
40.6%
Top prescribed drugs
Prednisone
644 claims
Methotrexate Sodium
557 claims
Hydroxychloroquine Sulfate
367 claims
Adalimumab
350 claims
Leflunomide
170 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
675
Unique beneficiaries
—
Total services
1,068
Distinct HCPCS
5
Medicare payment
$44K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 82 Rheumatology providers in IN — below median (cohort median 1,092).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
65
By payment type
Food and Beverage
$994
Education
$99
